Los resultados mostraron que, ya desde el inicio, quienes acabaron desarrollando ERC tenían niveles más altos de marcadores inflamatorios (IL-6, IL-1β o TNFα) y de daño oxidativo (malondialdehíd...
Read moreProceeds to support further clinical development of lead program ATX-01 in Myotonic Dystrophy Type1, a unique therapy currently in Phase I-IIa, targeting miR23b
Read moreEn el ámbito de la investigación clínica, la formación en Buenas Prácticas Clínicas (BPC) no es simplemente una formalidad: es un requisito esencial para garantizar la calidad, la ética y la le...
Read moreLa Unidad de Deterioro Cognitivo del centro hospitalario participa en tres ensayos clínicos y atiende a más de 3.500 pacientes cada año que padecen esta enfermedad neurodegenerativa
Read moreEl estudio sugiere actuar sobre el entorno del tumor, como alternativa a los tratamientos actuales que atacan directamente a las células tumorales
Read moreThe results of a phase 3 clinical trial show that orforglipron reduces body weight by an average of 11% and improves cardiovascular risk factors.
Read moreLa comunicación clínica efectiva, por tanto, no es solo una herramienta operativa, sino un factor estratégico en la gestión de ensayos clínicos. Las CROs que integran enfoques centrados en el p...
Read moreThe center is participating in an international clinical trial that seeks to improve patients' quality of life by addressing sleep, communication and motor disorders.
Read moreOryzon Genomics is proud to announce its participation as a sponsor of the first-ever Phelan-McDermid syndrome (PMS) burden of illness study. The study is led by CureShank, a research advocacy organiz...
Read moreWithin two sprints, the same team shipped safer, faster work by changing who owned validation, where audit trails lived, and which KPIs unlocked budget — not by buying another model. You’ll leave ...
Read moreIn the complex world of pharmaceutical and biotechnology drug development, PIVOTAL serves as your trusted medical partner – delivering expert medical oversight and strategic insight across every pha...
Read moreThe studies established the lead asset SYT-510 to be well tolerated in healthy volunteers at all doses with a good safety profile
Read more